Literature DB >> 9694057

Corticosteroid prescribing in rheumatoid arthritis and psoriatic arthritis.

W Grassi1, R De Angelis, C Cervini.   

Abstract

Corticosteroid usage was assessed in rheumatoid arthritis (RA) and psoriatic arthritis (PA) patients in Italy. A multicentre, observational study was undertaken in 10 Italian rheumatological centres from 1990 to 1992 using a computerised clinical data bank. Nine hundred and seven RA patients and 180 PA patients were studied; 510 (56.2%) RA patients and 44 (24.4%) PA patients were using corticosteroids. The percentage of patients taking corticosteroids ranged from 20.5 to 85.4% for RA patients and from 0 to 55% for PA patients for the different centres. Methylprednisolone was the most prescribed corticosteroid, both in RA patients (63.2%) and in PA patients (65.9%). The average methylprednisolone daily dose was 5.7+/-3.6 mg in RA patients and 4.5+/-1.4 mg in PA patients. The data provide evidence that corticosteroids are taken in an unexpectedly high percentage of patients with RA and PA in Italy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694057     DOI: 10.1007/bf01451052

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  New perspectives on treating rheumatoid arthritis.

Authors:  F C Breedveld
Journal:  N Engl J Med       Date:  1995-07-20       Impact factor: 91.245

Review 2.  ABC of rheumatology. Rheumatoid arthritis--II: Treatment.

Authors:  M Akil; R S Amos
Journal:  BMJ       Date:  1995-03-11

Review 3.  [Treatment of psoriatic rheumatism].

Authors:  P Goupille; J P Valat
Journal:  Ann Med Interne (Paris)       Date:  1994

Review 4.  Clinical management of rheumatoid arthritis.

Authors:  P M Brooks
Journal:  Lancet       Date:  1993-01-30       Impact factor: 79.321

5.  Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events.

Authors:  K G Saag; R Koehnke; J R Caldwell; R Brasington; L F Burmeister; B Zimmerman; J A Kohler; D E Furst
Journal:  Am J Med       Date:  1994-02       Impact factor: 4.965

6.  Cross-sectional study of rheumatoid arthritis treatment in a university hospital.

Authors:  W T Friesen; Y A Hekster; L B van de Putte; F W Gribnau
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

7.  Low dose glucocorticoid therapy in rheumatoid arthritis (RA): transitional or selected add-on therapy?

Authors:  A T Masi
Journal:  J Rheumatol       Date:  1983-10       Impact factor: 4.666

8.  Corticosteroid prescribing in rheumatoid arthritis--the fiction and the fact.

Authors:  M A Byron; A G Mowat
Journal:  Br J Rheumatol       Date:  1985-05

9.  Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines.

Authors: 
Journal:  Arthritis Rheum       Date:  1996-05

10.  Low dose prednisone therapy in rheumatoid arthritis: a double blind study.

Authors:  E D Harris; R D Emkey; J E Nichols; A Newberg
Journal:  J Rheumatol       Date:  1983-10       Impact factor: 4.666

View more
  2 in total

Review 1.  Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis.

Authors:  Sueli Carneiro; Penelope Esther Palominos; Sônia Maria Alvarenga Anti; Rodrigo Luppino Assad; Rafaela Silva Guimarães Gonçalves; Adriano Chiereghin; Andre Marun Lyrio; Antônio Carlos Ximenes; Carla Gonçalves Saad; Célio Roberto Gonçalves; Charles Lubianca Kohem; Cláudia Diniz Lopes Marques; Cláudia Goldenstein Schainberg; Eduardo de Souza Meirelles; Gustavo Gomes Resende; Lenise Brandao Pieruccetti; Mauro Waldemar Keiserman; Michel Alexandre Yazbek; Percival Degrava Sampaio-Barros; Ricardo da Cruz Lage; Rubens Bonfiglioli; Thauana Luíza Oliveira; Valderílio Feijó Azevedo; Washington Alves Bianchi; Wanderley Marques Bernardo; Ricardo Dos Santos Simões; Marcelo de Medeiros Pinheiro; Cristiano Barbosa Campanholo
Journal:  Adv Rheumatol       Date:  2021-11-24

2.  Management of Psoriatic Arthritis: Turkish League Against Rheumatism (TLAR) Expert Opinions.

Authors:  Kemal Nas; Erkan Kiliç; Remzi Çevik; Hatice Bodur; Şebnem Ataman; Figen Ayhan; Özgür Akgül; Ayşen Akinci; Zuhal Altay; Erhan Çapkın; Abdullah Zübeyir Dağli; Tuncay Duruöz; Gülcan Gürer; Feride Göğüş; Yeşim Garip; Cahit Kaçar; Ayhan Kamanli; Ece Kaptanoğlu; Taciser Kaya; Hilal Kocabaş; Erhan Ali Özdemirel; Sumru Özel; İlhan Sezer; İsmihan Sunar; Gürkan Yilmaz
Journal:  Arch Rheumatol       Date:  2018-05-21       Impact factor: 1.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.